article thumbnail

4mn dose shortage of GSK’s childhood rotavirus vaccine expected

European Pharmaceutical Review

“GSK communicated to GAVI earlier this year on manufacturing challenges leading to an unplanned, short-term drop in Rotarix production for 2022, for which priority mitigation plans are fully in place,” stated the publication. First dose measles coverage dropped to 81 percent in 2021, the lowest level since 2008, meaning 24.7

article thumbnail

Meet Our MVP: Lauren

BuzzRx

From day one, she has immersed herself in the company, taking advantage of marketing information, tips from fellow Reps, and the open line of communication between Managers and their teams via calls, text, and group threads. One of the reasons that Lauren has been so successful is her ability to stay organized and soak up information.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Precision Value & Health acquires Across Health

pharmaphorum

Pharma marketing specialist Precision Value & Health has acquired the specialist communications consultancy Across Health. Founded in 2008 and headquartered in Belgium, Across Health partners with blue-chip life science clients to design, execute, and track omnichannel strategies and digital transformation programs.

article thumbnail

How real human experiences can power a healthier future

pharmaphorum

The triple aim considers how we balance the needs of the individual with pressures on our health systems and, in a phrase coined by Berwick, Nola and Whittington in 2008, it is defined as: Improving an individual’s experience of care. Improving the health of populations. Reducing the per capita costs of care.

article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

In 2008, the startup launched its first API to make and receive phone calls entirely in the cloud. Their patient journey typically requires engaging with discrete service providers, who are often using antiquated means of communication. The power of the open-protocol approach has been realised across many industries.

HIPAA 98
article thumbnail

Show 1337: Pros and Cons of LASIK Eye Surgery

The People's Pharmacy

Cofer tells her story, including her testimony to the FDA and her experience as the Patient Representative at an advisory panel meeting for the agency in 2008. In 2008, she served as the Patient Representative at an FDA advisory panel meeting on LASIK issues. She was left with pain and impaired vision, especially in low light.

FDA 81
article thumbnail

Why pharma needs a revolution in culture

pharmaphorum

Moreover, fines levied for these activities, while not quite as hefty as those faced by the banks, nonetheless amounted to $50 billion from 2008 to 2018. Compliance systems by themselves are not enough. One surprisingly simple reason for this is that people choose whether to follow rules or not. Of course, having rules is necessary.